Patents by Inventor Jason W. Flora
Jason W. Flora has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250082004Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco.Type: ApplicationFiled: November 25, 2024Publication date: March 13, 2025Applicant: Philip Morris USA Inc.Inventors: Gerd KOBAL, Justin HEYNEKAMP, Timothy B. LANGSTON, Peter REEH, Munmaya K. MISHRA, Jason W. FLORA
-
Publication number: 20250034518Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.Type: ApplicationFiled: October 14, 2024Publication date: January 30, 2025Applicant: Philip Morris USA Inc.Inventors: Alec J. HAYES, Maria SHULLEETA, Jason W. FLORA
-
Patent number: 12161145Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco.Type: GrantFiled: August 26, 2021Date of Patent: December 10, 2024Assignee: Philip Morris USA Inc.Inventors: Gerd Kobal, Justin Heynekamp, Timothy B. Langston, Peter Reeh, Munmaya K. Mishra, Jason W. Flora
-
Patent number: 12116591Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.Type: GrantFiled: July 5, 2023Date of Patent: October 15, 2024Assignee: Philip Morris USA Inc.Inventors: Alec J. Hayes, Maria Shulleeta, Jason W. Flora
-
Publication number: 20230348849Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.Type: ApplicationFiled: July 5, 2023Publication date: November 2, 2023Applicant: Philip Morris USA Inc.Inventors: Alec J. HAYES, Maria SHULLEETA, Jason W. FLORA
-
Patent number: 11739292Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.Type: GrantFiled: May 23, 2022Date of Patent: August 29, 2023Assignee: Philip Morris USA Inc.Inventors: Alec J. Hayes, Maria Shulleeta, Jason W. Flora
-
Publication number: 20220282209Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.Type: ApplicationFiled: May 23, 2022Publication date: September 8, 2022Applicant: Philip Morris USA Inc.Inventors: Alec J. HAYES, Maria SHULLEETA, Jason W. FLORA
-
Publication number: 20210378281Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco.Type: ApplicationFiled: August 26, 2021Publication date: December 9, 2021Applicant: Philip Morris USA Inc.Inventors: Gerd KOBAL, Justin HEYNEKAMP, Timothy B. LANGSTON, Peter REEH, Munmaya K. MISHRA, Jason W. FLORA
-
Patent number: 11129405Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco. Also disclosed is a method of making such a product.Type: GrantFiled: November 2, 2018Date of Patent: September 28, 2021Assignee: Philip Morris USA Inc.Inventors: Gerd Kobal, Justin Heynekamp, Timothy B. Langston, Peter Reeh, Munmaya K. Mishra, Jason W. Flora
-
Patent number: 10280396Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.Type: GrantFiled: December 12, 2017Date of Patent: May 7, 2019Assignee: Philip Morris USA Inc.Inventors: Alec J. Hayes, Maria Shulleeta, Jason W. Flora
-
Publication number: 20190069595Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco. Also disclosed is a method of making such a product.Type: ApplicationFiled: November 2, 2018Publication date: March 7, 2019Applicant: Philip Morris USA Inc.Inventors: Gerd Kobal, Justin Heynekamp, Timothy B. Langston, Peter Reeh, Munmaya K. Mishra, Jason W. Flora
-
Patent number: 10117453Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco. Also disclosed is a method of making such a product.Type: GrantFiled: May 22, 2015Date of Patent: November 6, 2018Assignee: Philip Morris USA Inc.Inventors: Gerd Kobal, Justin Heynekamp, Timothy B. Langston, Peter Reeh, Munmaya K. Mishra, Jason W. Flora
-
Publication number: 20180105794Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.Type: ApplicationFiled: December 12, 2017Publication date: April 19, 2018Applicant: Philip Morris USA Inc.Inventors: Alec J. Hayes, Maria Shulleeta, Jason W. Flora
-
Patent number: 9862923Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.Type: GrantFiled: March 25, 2011Date of Patent: January 9, 2018Assignees: Philip Morris USA Inc., Philip Morris Products S.A.Inventors: Alec J. Hayes, Maria Shulleeta, Jason W. Flora
-
Publication number: 20150250227Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco. Also disclosed is a method of making such a product.Type: ApplicationFiled: May 22, 2015Publication date: September 10, 2015Applicant: PHILIP MORRIS USA INC.Inventors: Gerd Kobal, Justin Heynekamp, Timothy B. Langston, Peter Reeh, Munmaya K. Mishra, Jason W. Flora
-
Patent number: 9038643Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco. Also disclosed is a method of making such a product.Type: GrantFiled: November 7, 2011Date of Patent: May 26, 2015Assignee: Philip Morris USA Inc.Inventors: Gerd Kobal, Justin Heynekamp, Timothy B. Langston, Peter Reeh, Munmaya K. Mishra, Jason W. Flora, Tatjana Kichko
-
Publication number: 20120247492Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco. Also disclosed is a method of making such a product.Type: ApplicationFiled: November 7, 2011Publication date: October 4, 2012Applicant: Philip Morris USA Inc.Inventors: Gerd Kobal, Justin Heynekamp, Timothy B. Langston, Peter Reeh, Munmaya K. Mishra, Jason W. Flora
-
Publication number: 20120042889Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.Type: ApplicationFiled: March 25, 2011Publication date: February 23, 2012Applicant: Philip Morris USA Inc.Inventors: Alec J. Hayes, Maria Shulleeta, Jason W. Flora